Nephrol Dial Transplant (1994) 9: 637-641
© 1994 European Renal Association-European Dialysis and Transplant Association
research-article
Relationship between elevated creatine phosphokinase and the clinical spectrum of rhabdomyolysis
Renal Unit, Department of Internal Medicine, Academic Medical Center Amsterdam, The Netherlands
Correspondence and offprint requests to: Correspondence and offprint requests to: R. T. Krediet, Renal Unit, Department of Internal Medicine, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
The incidence, causes and complications of severe rhabdomyolysis (creatine phosphokinase (CK)
5000 U/l) were studied during a 7-year study period in a large university hospital population. This condition was present in 0.074% of all admitted patients. The mortality in the study group (n=93) was 32% and the incidence of acute renal failure (ARF) 51%. Ischaemia was the most frequent cause, and drugs, alcohol and/or coma were the second most common cause of severe rhabdomyolysis. Patients with rhabdomyolysis due to ischaemia were older, had ARF more often, and also had the highest mortality. Hyperkalaemia (potassium
5.5 mmol/1) occurred in 13% of the patients, and all of them had or developed an impaired renal function. Hypocalcaemia (calcium
2.00 mmol/1) was found in 41%. The incidence of ARF and electrolyte disturbances was higher in patients with CK levels exceeding 15 000 U/l. Mortality was significantly higher in patients with ARF. Plasma concentrations of potassium and calcium correlated better with the severity of renal failure than with the maximal height of plasma CK.
Keywords: acute renal failure; creatine phosphokinase; hyperkalaemia; hypocalcaemia; rhabdomyolysis
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
X. Bosch, E. Poch, and J. M. Grau Rhabdomyolysis and Acute Kidney Injury N. Engl. J. Med., July 2, 2009; 361(1): 62 - 72. [Full Text] [PDF] |
||||
![]() |
H. Talaie, A. Pajouhmand, M. Abdollahi, R. Panahandeh, H. Emami, S. Hajinasrolah, and M. Tghaddosinezhad Rhabdomyolysis among acute human poisoning cases Human and Experimental Toxicology, July 1, 2007; 26(7): 557 - 561. [Abstract] [PDF] |
||||
![]() |
J. A. Jaffe and P. L. Kimmel Chronic Nephropathies of Cocaine and Heroin Abuse: A Critical Review Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 655 - 667. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Grover, M. G. Atta, J. A. Eustace, T. S. Kickler, and D. M. Fine Lack of clinical utility of urine myoglobin detection by microconcentrator ultrafiltration in the diagnosis of rhabdomyolysis Nephrol. Dial. Transplant., October 1, 2004; 19(10): 2634 - 2638. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Henry Metabolic consequences of drug misuse Br. J. Anaesth., July 1, 2000; 85(1): 136 - 142. [Full Text] [PDF] |
||||




